DUBLIN, Sept. 2, 2022 /PRNewswire/ -- The "Blood Gas and Electrolyte Analyzers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Blood Gas and Electrolyte Analyzers Market to Reach $985 Million by 2026
Amid the COVID-19 crisis, the global market for Blood Gas and Electrolyte Analyzers estimated at US$814.7 Million in the year 2022, is projected to reach a revised size of US$985 Million by 2026, growing at a CAGR of 5.1% over the analysis period. Portable, one of the segments analyzed in the report, is projected to record 5.8% CAGR and reach US$681.6 Million by the end of the analysis period.
Growth in the global market is led by factors such as improving infrastructure in diagnostic centers, hospitals and clinical laboratories and rise in integration of critical equipment such as analyzers in ICUs, NICUs, and emergency and trauma units.
Market growth is significantly boosted by the rising number of patients in critical care units and intensive care units (ICU); and the increasing demand for integrated, high-throughput systems that measure multiple parameters (such as creatinine, urea, nitrogen) in a short time, which is crucial for emergency situations.
Another driver for the global market is increasing adoption of these devices across hospitals, emergency wards and diagnostic centers. The growing relevance of point-of-care diagnosis within the healthcare industry due to its numerous advantages such as bedside care is poised to propel the market demand.
Increasing spending on handheld, compact blood gas analyzers offering faster results and addressing needs of critical care services, operation rooms and emergency healthcare services will further boost global demand. Advanced devices are expected to facilitate functions like self-monitoring along with little intervention of lab or respiratory staff through automation.
Ongoing advances in sensor and analyzer technology are anticipated to bring devices and testing of blood gas closer to patients, while allowing medical professionals to efficient monitor different conditions.
After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Benchtop segment is readjusted to a revised 3.8% CAGR for the next 7-year period. The growing penetration of Point-of-Care (PoC) patient monitoring instruments, coupled with continued innovations and technology improvements taking place in the portable / handheld blood gas analyzers is encouraging end users to switchover to the PoC version.
Benchtop blood gas analyzer, also known as central laboratory analyzer, is generally placed in central laboratories of large hospitals, to undertake high volumes of blood gas testing. Due to the time critical nature of blood gas tests, especially in critical care departments, benchtop analyzers are moving out of the central laboratory and are being placed in near-patient locations in critical care areas such as ICU, CCU, ED, and OR.
What`s New for 2022?
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to the digital archives
Complimentary updates for one year
Key Topics Covered:
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Life-Saving Interventions for COVID-19 Patients Drive Importance of Blood Gas & Electrolyte Analyzers
Industry Witnesses Inflow of Sophisticated Solutions
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Blood Gas and Electrolyte Analyzers: An Introduction
Types of Analyzers
Fundamentals of Blood Gases and Blood Gas Testing
Blood Gas Parameters and their Significance
Point-of-Care Analyzers Gain Significance
Hurdles to Overcome
Recent Industry Activity
2. FOCUS ON SELECT PLAYERS (Total 53 Featured)
Abbott Point of Care Inc.
Cornley Hi-tech Co., LTD
Radiometer Medical ApS
EDAN Instruments, Inc.
ERBA Diagnostics Mannheim GmbH
F Hoffman La Roche Ltd.
I Sens Inc
Nova Biomedical Corporation
OPTI Medical Systems, Inc.
Perlong Medical Equipment Co., Ltd.
Siemens Medical Solutions USA, Inc.
Tecom Analytical System
3. MARKET TRENDS & DRIVERS
Decentralized Testing Gains Traction
Technology Advancements: Cornerstone for Market Growth
Select New Devices
Advanced Sensors Give Way to Modern Devices
Blood Gas Testing Becomes Commonplace in Critical Care
Benchtop Makers Cash in on the Lucrative POC Market
Advanced Solutions for Point-of-Care & Critical Care Settings
Integration with LIS and EMR Widens Functionality
Miniaturised Blood Gas Analysers Gain Traction
Increasing Prevalence of Chronic Disorders and Patient admissions Fuels Market Growth
Assessment of Various Conditions Based on Blood Gas Testing
Alarming Levels of Diabetes Incidence Worldwide Drives Demand
World Diabetes Prevalence (2000-2019)
Rise in CVD Incidence Spurs Demand
Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
Rising Cancer Incidence and Ensuing Rise in Critical Care Admissions Create Need for Blood Gas and Electrolyte Analyzers
Rise in Prevalence of COPD Augments Demand
Global Prevalence of COPD by Age Group: Percentage of Men and Women Affected by the Condition
Rising Aging Population: Principal Driver for the BGA Market
Healthcare Cost-Cutting Trend Promotes Innovations
4. GLOBAL MARKET PERSPECTIVE
III. REGIONAL MARKET ANALYSIS
For more information about this report visit https://www.researchandmarkets.com/r/7zxo63
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/global-blood-gas-and-electrolyte-analyzers-market-report-2022-amid-the-covid-19-crisis-market-to-reach-985-million-by-2026-301617089.html
SOURCE Research and Markets